Intradermal Rabies Immunization using NanoJect TM

• Unité de recherche: INNOSUISSE
• Numéro de projet: 13378.1;6 PFFLE-LS
• Titre du projet anglais: Intradermal Rabies Immunization using NanoJect TM

Description succincte (Anglais)

Intradermal Rabies Immunization using NanoJect TM

Description succincte (Français)

Intradermal Rabies Immunization using NanoJect TM

Résumé des résultats (Abstract) (Anglais)

Debiotech received in 2008 the CTI Medtech Award for its innovative NanoJect microneedles and further succeeded in manufacturing functional and reproducible devices. The major obstacle today is the lack of human clinical data relating to intradermal injection of drug, in particular vaccines, with NanoJect. The aim of the project is to demonstrate the efficacy and clinical benefit of NanoJect in collaboration with one of the leading academic research centers for vaccines in Europe. It will thereby give Debiotech the access to the highly dynamic vaccine market.

Résumé des résultats (Abstract) (Français)

Debiotech received in 2008 the CTI Medtech Award for its innovative NanoJect microneedles and further succeeded in manufacturing functional and reproducible devices. The major obstacle today is the lack of human clinical data relating to intradermal injection of drug, in particular vaccines, with NanoJect. The aim of the project is to demonstrate the efficacy and clinical benefit of NanoJect in collaboration with one of the leading academic research centers for vaccines in Europe. It will thereby give Debiotech the access to the highly dynamic vaccine market.